Hunan Jiudian Pharmaceutical Co., Ltd. (SHE: 300705)
China flag China · Delayed Price · Currency is CNY
23.58
-0.12 (-0.51%)
Oct 11, 2024, 3:04 PM CST

Hunan Jiudian Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Oct '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 2018 - 2014
Market Capitalization
11,54511,4698,3338,2476,2892,884
Upgrade
Market Cap Growth
42.90%37.63%1.05%31.12%118.06%4.77%
Upgrade
Enterprise Value
11,30111,2288,3628,2746,2652,924
Upgrade
Last Close Price
23.5823.5217.0417.4113.266.06
Upgrade
PE Ratio
24.9730.7829.0939.3074.2351.66
Upgrade
PS Ratio
4.004.263.585.076.433.12
Upgrade
PB Ratio
5.275.815.377.507.533.79
Upgrade
P/FCF Ratio
40.382626.25-57.71126.9887.79-31.61
Upgrade
P/OCF Ratio
19.9626.6030.9843.2141.9331.79
Upgrade
EV/Sales Ratio
3.984.173.595.086.413.16
Upgrade
EV/EBITDA Ratio
21.1825.2724.7031.2549.5732.43
Upgrade
EV/EBIT Ratio
24.8929.9329.9939.1880.1755.38
Upgrade
EV/FCF Ratio
39.532570.94-57.91127.4187.45-32.04
Upgrade
Debt / Equity Ratio
0.190.200.200.300.110.18
Upgrade
Debt / EBITDA Ratio
0.760.880.931.240.701.55
Upgrade
Debt / FCF Ratio
1.4289.40-2.195.061.23-1.54
Upgrade
Asset Turnover
1.031.041.151.130.890.92
Upgrade
Inventory Turnover
2.372.452.291.991.752.46
Upgrade
Quick Ratio
3.072.752.122.121.801.40
Upgrade
Current Ratio
3.993.442.722.752.782.26
Upgrade
Return on Equity (ROE)
23.45%20.89%20.34%21.11%10.30%7.44%
Upgrade
Return on Assets (ROA)
10.24%9.07%8.62%9.18%4.43%3.27%
Upgrade
Return on Capital (ROIC)
12.22%11.08%10.57%11.23%5.35%3.88%
Upgrade
Earnings Yield
4.00%3.21%3.24%2.48%1.31%1.91%
Upgrade
FCF Yield
2.48%0.04%-1.73%0.79%1.14%-3.16%
Upgrade
Dividend Yield
0.97%0.97%0.99%0.76%0.17%0.30%
Upgrade
Payout Ratio
26.10%25.69%25.70%7.35%16.74%28.13%
Upgrade
Buyback Yield / Dilution
-2.78%-4.64%0.15%-0.12%1.89%-3.17%
Upgrade
Total Shareholder Return
-1.81%-3.66%1.14%0.64%2.05%-2.87%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.